Procter & Gamble Health Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2025, recommended Final Dividend of 45 per equity share.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Procter & Gamble Health Limited, at its meeting held on May 29, 2025, has recommended a Final Dividend of ₹45 per equity share for its shareholders. This is a recommendation that will need shareholder approval at the upcoming Annual General Meeting. The dividend will be paid to shareholders whose names appear in the company's register on the record date, which will be announced separately. The company operates in the healthcare and pharmaceutical sector in India.
Shareholders will receive a ₹45 per share payout if approved at the AGM, providing direct cash returns. Given the stock's typically high share price, the yield percentage is modest. The announcement signals financial stability and consistent shareholder returns from the company.